- Align Technology won a patent infringement case in the Jinan Intermediate People's Court in China against Angelalign Technology's Chinese operating subsidiaries.
- The court ruled that Angelalign infringed Align's patent rights through specific biomechanical simulation and digital orthodontic treatment design systems.
- Angelalign was ordered to cease using the technology and infringing product operations, and was awarded RMB 10 million in damages.
- Angelalign posted a 41.9% to 43.1% year-on-year revenue increase to between $229 million and $231 million, alongside a 69% to 78.9% profit jump in the first half of 2026.
- The company's international sales volume reached 168,000 cases, surpassing its domestic sales volume of 148,600 cases during the same period.
- These strong financial gains were driven by growing consumer awareness and successful global expansion, despite price pressures from China's national procurement program.